Your Ultimate FTSE 100 4-Stock Balanced Portfolio: SSE PLC, AstraZeneca plc, Banco Santander SA & Unilever plc

SSE PLC (LON:SSE), AstraZeneca plc (LON:AZN), Banco Santander SA (LON:BNC) and Unilever plc (LON:ULVR) provide a potent mix of income and capital growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

Sometimes it’s tough to strike the right balance between growth and income. Indeed, most investors tend to focus on one or the other, as opposed to creating a portfolio that provides them with a decent income while also having the potential to post impressive capital gains.

With that in mind, here are four stocks that, together, offer impressive dividends as well as exciting future prospects.

SSE

As far as income plays go, few stocks in the FTSE 100 can match SSE (LSE: SSE). That’s because it currently yields a hugely impressive 6% and, better still, dividends per share are all set to rise by at least the inflation rate over the medium term.

This may not sound like such an appealing option when inflation is less than 2%. However, with the scale of quantitative easing having the potential to push the inflation rate much higher over the medium term, SSE’s planned dividend increases could become a real asset. Indeed, they could help to maintain your income levels in real terms moving forward.

AstraZeneca

While also offering a respectable yield of 3.6%, AstraZeneca (LSE: AZN) comes with huge capital growth potential. That’s because its drugs pipeline is undergoing nothing short of a transformation right now.

Certainly, the company’s bottom line is due to be hit by continued fallout from the current patent cliff, with earnings forecast to fall by 13% this year and by 6% next year. However, looking beyond that, numerous acquisitions have made AstraZeneca’s pipeline a hot ticket. Indeed, further bids from global rivals are a very real possibility, which would clearly be good news for shareholders.

Banco Santander

Few companies offer the potent mix of income and growth that Santander (LSE: BNC) does. It currently yields a whopping 7.4% and offers huge growth potential. For instance, earnings per share (EPS) are due to increase by 23% in the current year and by 21% next year. This is well ahead of the market average and shows that Santander is a true growth play.

Of course, investors are being asked to pay a premium for such strong growth potential, with shares in Santander currently trading on a price to earnings (P/E) ratio of 15.6. This is much higher than the FTSE 100’s P/E of 13.8. However, when Santander’s growth forecasts are taken into account, it equates to a price to earnings growth (PEG) ratio of just 0.6, which shows that for the level of growth on offer, Santander trades at a reasonable price.

Unilever

With a yield of 3.3% and forecast growth in earnings of 9% next year, Unilever (LSE: ULVR) seems to strike the right balance between growth and income. Indeed, the consumer goods play seems to have a very bright future ahead of it.

For instance, customer loyalty in its brands is constantly increasing in the developing world, where Unilever has invested vast amounts of time and money to ensure the long term growth of its products. This exposure (emerging markets account for over half of Unilever’s revenue) could prove to be highly beneficial for investors moving forward, as greater wealth and consumer spending are anticipated across the developing world. As a result, shares in the company could deliver impressive gains over the medium term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and SSE. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »